Recombinant Mouse PPT1 Protein，His

The study of PPT1 (palmitoyl-protein thioesterase 1) has gained significant attention due to its critical role in the pathogenesis of neurodegenerative disorders, particularly Batten disease, a severe childhood neurodegeneration caused by genetic mutations in the PPT1 gene. PPT1 is an enzyme responsible for the removal of palmitate from proteins, a post-translational modification that influences membrane localization, protein stability, and cellular signaling. Deficiencies in PPT1 activity lead to the accumulation of palmitoylated proteins in neuronal cells, contributing to cellular dysfunction and neurodegeneration. Research into PPT1 has focused on understanding its enzymatic mechanisms, substrate specificity, and the biochemical pathways affected by its deficiency. Additionally, therapeutic strategies, including gene therapy, small molecule compounds, and enzyme replacement therapies, are being explored to restore PPT1 function and mitigate the progression of associated neurodegenerative diseases. As advances are made in elucidating PPT1's biological roles and interactions, the findings hold promise for developing novel approaches to treat or even prevent the onset of disorders linked to PPT1 deficiency, underscoring the importance of continued research in this field.